Difference in mortality after hip fracture is associated with postdischarge prescription of antithrombotic prophylaxis: A case-control study

Clinical and Applied Thrombosis/Hemostasis

Volumn 8, Issue 2, 2002, Pages 143-146

  Grion, Anna Maria ^a   Gallo, Umberto ^a   Bano, Francesca ^a   Ragazzi, Michele ^a   Cestrone, Adriano ^a   Orsini, Arturo ^a   Salomoni, Marina ^a   Gaion, Rosa Maria ^a   Pengot, Vittorio ^a,b  

^a UNIVERSITY OF PADOVA   (Italy)

^b UNIVERSITY OF PADUA MEDICAL SCHOOL   (Italy)

Author keywords

Antithrombotic prophylaxis; Hip fracture

Indexed keywords

ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; ANTIVITAMIN K; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; FIBRINOLYTIC AGENT;

AGED; ANTICOAGULANT THERAPY; ARTICLE; CAUSE OF DEATH; CONFIDENCE INTERVAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HIGH RISK POPULATION; HIP FRACTURE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRESCRIPTION; PRIORITY JOURNAL; SURVIVAL; THROMBOSIS; TREATMENT OUTCOME; AMBULATORY CARE; CASE CONTROL STUDY; RETROSPECTIVE STUDY; RISK;

AGED; AGED, 80 AND OVER; AMBULATORY CARE; CASE-CONTROL STUDIES; FEMALE; FIBRINOLYTIC AGENTS; HIP FRACTURES; HUMANS; MALE; ODDS RATIO; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; THROMBOSIS;

EID: 0035992595     PISSN: 10760296     EISSN: None     Source Type: Journal    
DOI: 10.1177/107602960200800210     Document Type: Article

References (14)

1. Hip fracture
2. Death after proximal femoral fracture: An autopsy study
3. Natural history of thromboembolic disease after total hip arthroplasty
4. Significance of deep venous thrombosis in the lower extremity after total joint arthroplasty
5. Prevention of venous thromboembolism
6. Differences in mortality after fracture of hip: The East Anglian audit
7. A comparison of internal fixation and prosthetic replacement for recent displaced subcapital fractures of the neck of the femur
8. A comparison of the use of internal fixation and prosthetic replacement for fresh fractures of the neck of the femur
9. A prospective study on the socioeconomic aspects of fracture of the proximal femur
10. Low molecular weight heparin (enoxaparin) as prophylaxis against VTE after total hip replacement
11. Efficacy and safety of prolonged thromboprophylaxis with a low molecular weight heparin (dalteparin) after total hip arthroplasty: The Danish prolonged prophylaxis (DaPP) study
12. Prolonged thromboprophylaxis following hip replacement surgery - Results of a double-blind, prospective, randomized, placebo-controlled study with dalteparin (Fragmin)
13. Risk of deep venous thrombosis after hospital discharge in patients having undergone total hip replacement: Double-blind randomized comparison of enoxaparin versus placebo
14. Low molecular weight prophylaxis using dalteparin extended out-of-hospital warfarin versus out-of-hospital placebo in hip arthroplasty patients. A double-blind randomized comparison